Merit Medical Systems Inc (MMSI)

$67.05

-0.22

(-0.33%)▲

Live

Insights on Merit Medical Systems Inc

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 287.17M → 320.05M (in $), with an average increase of 3.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 33.40M → 20.24M (in $), with an average decrease of 20.1% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 42.9% return, outperforming this stock by 30.7%

Performance

  • $66.94
    $67.75
    $67.05
    downward going graph

    0.17%

    Downside

    Day's Volatility :1.2%

    Upside

    1.03%

    downward going graph
  • $54.66
    $85.62
    $67.05
    downward going graph

    18.48%

    Downside

    52 Weeks Volatility :36.16%

    Upside

    21.69%

    downward going graph

Returns

PeriodMerit Medical Systems IncSector (Health Care)Index (Russel 2000)
3 Months
-16.87%
-3.2%
0.0%
6 Months
-10.02%
-2.7%
0.0%
1 Year
12.23%
0.8%
-0.4%
3 Years
52.99%
22.3%
14.9%

Highlights

Market Capitalization
4.0B
Book Value
$20.89
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
1.49
PE Ratio
45.12
PEG Ratio
2.2
Wall Street Target Price
89.63
Profit Margin
7.48%
Operating Margin TTM
9.19%
Return On Assets TTM
3.97%
Return On Equity TTM
7.87%
Revenue TTM
1.2B
Revenue Per Share TTM
20.95
Quarterly Revenue Growth YOY
8.5%
Gross Profit TTM
519.1M
EBITDA
193.3M
Diluted Eps TTM
1.49
Quarterly Earnings Growth YOY
0.3
EPS Estimate Current Year
2.88
EPS Estimate Next Year
3.2
EPS Estimate Current Quarter
0.75
EPS Estimate Next Quarter
0.7

Analyst Recommendation

Buy
    78%Buy
    21%Hold
    0
    0%Sell
Based on 14 Wall street analysts offering stock ratings for Merit Medical Systems Inc(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 33.68%

Current $67.05
Target $89.63

Company Financials

FY17Y/Y Change
Revenue
727.9M
↑ 20.54%
Net Income
27.5M
↑ 36.79%
Net Profit Margin
3.78%
↑ 0.45%
FY18Y/Y Change
Revenue
882.8M
↑ 21.28%
Net Income
42.0M
↑ 52.66%
Net Profit Margin
4.76%
↑ 0.98%
FY19Y/Y Change
Revenue
994.9M
↑ 12.7%
Net Income
5.5M
↓ 87.03%
Net Profit Margin
0.55%
↓ 4.21%
FY20Y/Y Change
Revenue
963.9M
↓ 3.11%
Net Income
-9.8M
↓ 280.57%
Net Profit Margin
-1.02%
↓ 1.57%
FY21Y/Y Change
Revenue
1.1B
↑ 11.5%
Net Income
48.5M
↓ 592.27%
Net Profit Margin
4.51%
↑ 5.53%
FY22Y/Y Change
Revenue
1.2B
↑ 7.09%
Net Income
74.5M
↑ 53.79%
Net Profit Margin
6.47%
↑ 1.96%
Q1 FY22Q/Q Change
Revenue
275.4M
↓ 1.1%
Net Income
10.5M
↓ 48.84%
Net Profit Margin
3.83%
↓ 3.57%
Q2 FY22Q/Q Change
Revenue
295.0M
↑ 7.1%
Net Income
15.3M
↑ 45.07%
Net Profit Margin
5.19%
↑ 1.36%
Q3 FY22Q/Q Change
Revenue
287.2M
↓ 2.64%
Net Income
15.3M
↓ 0.17%
Net Profit Margin
5.32%
↑ 0.13%
Q4 FY22Q/Q Change
Revenue
293.4M
↑ 2.17%
Net Income
33.4M
↑ 118.71%
Net Profit Margin
11.38%
↑ 6.06%
Q1 FY23Q/Q Change
Revenue
297.6M
↑ 1.41%
Net Income
20.7M
↓ 38.02%
Net Profit Margin
6.96%
↓ 4.42%
Q2 FY23Q/Q Change
Revenue
320.1M
↑ 7.56%
Net Income
20.2M
↓ 2.21%
Net Profit Margin
6.33%
↓ 0.63%
FY17Y/Y Change
Total Assets
1.1B
↑ 17.93%
Total Liabilities
435.5M
↓ 2.06%
FY18Y/Y Change
Total Assets
1.6B
↑ 45.71%
Total Liabilities
687.2M
↑ 57.81%
FY19Y/Y Change
Total Assets
1.8B
↑ 8.48%
Total Liabilities
807.4M
↑ 17.48%
FY20Y/Y Change
Total Assets
1.7B
↓ 5.29%
Total Liabilities
705.8M
↓ 12.58%
FY21Y/Y Change
Total Assets
1.6B
↓ 0.97%
Total Liabilities
608.5M
↓ 13.79%
FY22Y/Y Change
Total Assets
1.6B
↓ 0.94%
Total Liabilities
543.9M
↓ 10.62%
Q1 FY22Q/Q Change
Total Assets
1.6B
↓ 1.13%
Total Liabilities
573.2M
↓ 5.8%
Q2 FY22Q/Q Change
Total Assets
1.6B
↑ 0.11%
Total Liabilities
558.2M
↓ 2.62%
Q3 FY22Q/Q Change
Total Assets
1.6B
↑ 0.07%
Total Liabilities
543.9M
↓ 2.56%
Q4 FY22Q/Q Change
Total Assets
1.7B
↑ 1.91%
Total Liabilities
519.6M
↓ 4.47%
Q1 FY23Q/Q Change
Total Assets
1.7B
↑ 1.21%
Total Liabilities
512.5M
↓ 1.37%
Q2 FY23Q/Q Change
Total Assets
1.8B
↑ 9.11%
Total Liabilities
633.9M
↑ 23.69%
FY17Y/Y Change
Operating Cash Flow
62.7M
↑ 17.03%
Investing Cash Flow
-146.8M
↓ 7.76%
Financing Cash Flow
96.5M
↓ 20.3%
FY18Y/Y Change
Operating Cash Flow
86.5M
↑ 37.95%
Investing Cash Flow
-378.8M
↑ 158.12%
Financing Cash Flow
328.3M
↑ 240.13%
FY19Y/Y Change
Operating Cash Flow
77.8M
↓ 10.08%
Investing Cash Flow
-134.5M
↓ 64.5%
Financing Cash Flow
33.5M
↓ 89.79%
FY20Y/Y Change
Operating Cash Flow
165.3M
↑ 112.39%
Investing Cash Flow
-58.7M
↓ 56.39%
Financing Cash Flow
-95.7M
↓ 385.41%
FY21Y/Y Change
Operating Cash Flow
147.2M
↓ 10.91%
Investing Cash Flow
-37.2M
↓ 36.64%
Financing Cash Flow
-98.4M
↑ 2.85%
Q1 FY22Q/Q Change
Operating Cash Flow
12.0M
↓ 73.79%
Investing Cash Flow
-9.9M
↓ 32.44%
Financing Cash Flow
-14.2M
↓ 56.14%
Q2 FY22Q/Q Change
Operating Cash Flow
38.8M
↑ 222.93%
Investing Cash Flow
-13.4M
↑ 36.11%
Financing Cash Flow
-13.2M
↓ 7.28%
Q3 FY22Q/Q Change
Operating Cash Flow
35.5M
↓ 8.5%
Investing Cash Flow
-16.8M
↑ 24.85%
Financing Cash Flow
-27.1M
↑ 104.99%

Technicals Summary

Sell

Neutral

Buy

Merit Medical Systems Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Merit Medical Systems Inc
Merit Medical Systems Inc
5.27%
-10.02%
12.23%
52.99%
4.7%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-6.38%
13.09%
42.92%
22.1%
55.85%
Resmed Inc.
Resmed Inc.
-6.04%
-34.35%
-36.79%
-15.35%
31.7%
Becton, Dickinson And Company
Becton, Dickinson And Company
-5.12%
4.29%
9.25%
8.72%
2.18%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-8.63%
5.96%
41.23%
28.23%
208.41%
Alcon Ag
Alcon Ag
-9.19%
6.36%
19.54%
27.84%
27.84%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Merit Medical Systems Inc
Merit Medical Systems Inc
45.12
45.12
2.2
2.88
0.08
0.04
0.0
20.89
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
74.68
74.68
3.27
5.59
0.12
0.07
0.0
33.82
Resmed Inc.
Resmed Inc.
23.74
23.74
1.74
6.52
0.24
0.12
0.01
28.08
Becton, Dickinson And Company
Becton, Dickinson And Company
46.61
46.61
2.31
12.22
0.06
0.03
0.01
89.4
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
53.94
53.94
4.06
7.85
0.2
0.12
0.0
37.17
Alcon Ag
Alcon Ag
112.22
112.22
NA
2.75
0.02
0.02
0.0
40.44
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Merit Medical Systems Inc
Merit Medical Systems Inc
Buy
$4.0B
4.7%
45.12
7.48%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$103.6B
55.85%
74.68
21.38%
Resmed Inc.
Resmed Inc.
Buy
$21.3B
31.7%
23.74
21.25%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$74.8B
2.18%
46.61
8.74%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$27.4B
208.41%
53.94
18.1%
Alcon Ag
Alcon Ag
Buy
$40.5B
27.84%
112.22
3.99%

Institutional Holdings

  • BlackRock Inc

    17.72%

  • Vanguard Group Inc

    12.14%

  • William Blair Investment Management, LLC

    5.86%

  • Conestoga Capital Advisors, LLC

    3.63%

  • State Street Corporation

    3.61%

  • ArrowMark Colorado Holdings, LLC (ArrowMark Partners)

    3.17%

Company Information

merit medical systems, inc. (nasdaq: mmsi) is a leading manufacturer of medical devices used in diagnostic & interventional cardiology & radiology procedures. its primary products consist of inflation devices used in angioplasty, stent placement & discography; diagnostic & therapeutic catheters used for various procedures in cardiology & radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage & monitor the administration of contrast & other fluid solutions during diagnostic & therapeutic procedures; thrombolytic catheters & fluid dispensing systems; angiography accessories; & standard & custom angiography kits. headquartered in south jordan, utah, a suburb of salt lake city, merit employs approximately 1,900 people worldwide. merit markets its products in the united states & europe (direct sales force) & the world (distributors). they call directly on physicians & clinicians in hospitals & clinics worldwide. the c

Organization
Merit Medical Systems Inc
Employees
6846
CEO
Mr. Fred P. Lampropoulos
Industry
Health Technology

Discover More

FAQs